ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 713326 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 713326; 2) Community: the network communities that were significantly associated with the response to NSC 713326; 3) Molecule: the relationships between components within communities and NSC 713326; 4) MDR: the compounds that were significantly associated with the NSC 713326.

NSC Compound Enrichment Correlation
NSC 763232 Null 0.0102077332082017 0.46421038
NSC 87500 Solacongestidine 0.0102077332082017 0.35297373
NSC 725191 1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol 0.0102962192514438 0.46820281
NSC 736164 pyrazoline derivative 0.0102962192514438 0.40971627
NSC 737613 Null 0.0102962192514438 0.3638022
NSC 749292 3-methoxy-1-nitrosopyrido[3,2:4,5]pyrrolo[1,2-c][1,2,3]benzotriazine 0.0102962192514438 0.53049664
NSC 125066 Bleomycin sulfate 0.0102962192514439 -0.094818613
NSC 136468 Null 0.0102962192514439 0.22424277
NSC 20200 [Diisobutyl(phenoxyethoxy)ethyl]dimethylbenzylammonium chloride 0.0102962192514439 0.11684828
NSC 293046 Carbamimidothioic acid, (4-oxo-2-phenyl-4H-1-benzopyran-8-yl)methyl ester, monohydrobromide 0.0102962192514439 0.30956453
Total:92  Current:22    [First] [Prev] [Next] [Last]